| Last Updated:
Creating DOI. Please wait...
This project will compare the attributes of existing cost effectiveness analyses (CEAs) of pharmaceuticals with those conducted on medical/surgical procedures. The analysis may shed light on the underlying reasons for the disproportionate differences in the types of healthcare intervention undergoing CEAs and suggest policy changes that could move toward greater balance.
CC-By Attribution 4.0 International